9 May 2024
Biofortuna completes acquisition of biological sample storage experts Cryoniss
Biofortuna Limited, the specialist laboratory services and CDMO, has completed the acquisition of Cryoniss Ltd, underlining its commitment to support life-changing research and development across the global biotech and life sciences sector. The acquisition of Cryoniss brings...
24 April 2024
CroBio announces completion of $1.55 million seed round
CroBio has announced the completion of $1.55 million seed round. The round was led by The Grantham Foundation for the Protection of the Environment, with participating investors – SOSV and Ponderosa Ventures, and with continued support from Catapult Ventures. Read the company...
22 April 2024
Precision neuroscience company Monument Therapeutics announces £1.5m funding to kickstart schizophrenia clinical development
Manchester, UK, and Cambridge UK, 18 April 2024 - Monument Therapeutics, a precision neuroscience company, today announced new funding of £1.5 million from a combination of equity investment and non-dilutive grant as part of the Innovate UK Future Economy Investor Partnership...
9 April 2024
Maxwellia revolutionises menstrual health category in pharmacy with the introduction of Evana® and Ultravana®
Alderley Park, Cheshire, UK - April 08, 2024 - Women’s health champion Maxwellia is pleased to announce the availability of Evana® Heavy Period Relief 500mg tablets (tranexamic acid) and Ultravana® Period Pain Relief 250mg tablets (naproxen) to help women manage heavy and...
20 March 2024
Sight and Sound announces partnership with Speaksee
Sight and Sound has joined forces with Dutch technology company Speaksee to deliver cutting-edge solutions in the UK. Speaksee’s innovative technology allows for real-time transcription of conversations, making it easier for individuals with hearing loss to follow along and...
7 March 2024
Oxford BioTherapeutics announces launch of enhanced discovery platform, OGAP®-Verify, at World ADC Conference 2024
• OGAP®-Verify allows for significantly enhanced sensitivity and specificity for improved target selection, dramatically accelerating drug target discovery … • OGAP-Verify is now more sensitive than Immunohistochemistry (IHC), measuring membrane proteins as low as 50...
5 March 2024
Pill Connect announces its acceptance onto the leading CDMO’s smart packaging supply program
Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organization) smart packaging supply program. Following an intensive validation process, the device has passed the product qualification...
21 February 2024
Maxwellia announces the launch of LoviTest™
Alderley Park, Cheshire, UK - February 21, 2024 - Maxwellia is delighted to announce the launch of LoviTest™, a convenient at-home STI testing service for chlamydia and gonorrhoea. LoviTest marks the latest addition to Maxwellia's direct-to-consumer (D2C) sexual health offering...
20 February 2024
LoviOne® crowned winner of the Pharmacy Product of the Year - Consumers’ Choice 2024
LoviOne®, Maxwellia’s emergency contraceptive pill brand, has been crowned winner of the Pharmacy Product of the Year Consumers’ Choice 2024. The highly anticipated Pharmacy Product of the Year awards are voted on by independent pharmacies and their customers, allowing them to...
14 February 2024
Innovation funding boost for blister prevention firm
The Wirral-based business behind PelliTec blister prevention technology has secured grant funding from Innovate UK. Building on the success of former Innovate UK programmes, like Women in Innovation and Young Innovators, the innovation agency is awarding £6.2m to firms...